v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (1,325,547) $ (566,359)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 431
Stock-based compensation 127,450
Shares issued for services 50,000 30,017
Loss on conversion of notes 92,959
Amortization of debt discount 4,029
Imputed interest 2,360
Changes in operating assets and liabilities:    
Prepaid expense (791,298)
Accounts payable 92,898 85,543
Accrued expenses (608,229) 412,635
Deferred revenue 22,000
Net cash used in operating activities (2,361,336) (9,775)
Cash flows from investing activities:    
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from issuance of common stock (initial public offering), net of issuance costs 7,293,651
Proceeds from notes payable 100,000 23,750
Payments of notes payable (299,950)
Proceeds from short term insurance financing 629,486
Net cash provided by financing activities 7,723,187 23,750
Net increase in cash and cash equivalents 5,361,851 13,975
Cash and cash equivalents, beginning of period 57,670 10,014
Cash and cash equivalents, end of period 5,419,521 23,989
Supplemental cash flow information:    
Cash paid for interest 83,074 1,444
Cash paid for taxes
Supplemental non-cash activity    
Reclassification of warrant 11,097
Issuing of common stock upon conversion of notes payable 1,535,615
Issuance of common stock for services $ 50,000  

Source

PDF HTML 10-Q Filing
ZIP XLS XBRL